AI & Technology6 min read
AI governance in regulated industries: a practical starting point
Boards want AI, regulators want controls. Here’s a pragmatic framework for shipping AI you can defend.
Read the perspectiveInsights
Signals from the frontier of life sciences.
Where AI, evidence, and human health are heading — and what leaders should do about it now.
Life Sciences5 min read
From CSV to CSA: rethinking computer system validation
Computer Software Assurance promises less paperwork and more risk focus. What changes in practice?
April 2026Read
Talent4 min read
Hiring scarce technical talent without compromising on quality
How leading teams source regulatory, validation, and ML specialists in a tight market.
March 2026Read
Future of AI7 min read
Agentic AI is about to rewrite pharma commercialization
Autonomous agents can compress insight cycles from quarters to days. What that means for launch and field strategy.
June 2026Read
Evidence6 min read
Real-world evidence at scale: from data lakes to decisions
RWE only creates value when it reaches the decision. A blueprint for evidence that payers and regulators trust.
May 2026Read
Clinical5 min read
Decentralized trials and the personalized-medicine ecosystem
Patient-centric trials and precision therapies are converging. Orchestrating the ecosystem is the real challenge.
April 2026Read
Sustainability5 min read
The climate–health convergence is a strategy question
Resilient supply chains and sustainable value creation are becoming inseparable from health outcomes.
March 2026Read
Have a problem worth solving well?
Tell us what you’re working on. We’ll tell you, honestly, how we can help.